Developer of a microbial biotechnology platform designed to change production models of high-value molecules. Abolis is based in Paris, France. Its last known valuation is $53.1 million. It has raised $40.1 million.
Last price · $/share
—
Implied valuation
$53.1M
Total raised
$40.1M
Last round
—
Team — not yet on record
No current team members for Abolis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Abolis with a free account
·Watch Abolis: the Monday email on marks, rounds and moves
